Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung

European Journal of Nuclear Medicine

Volumn 23, Issue 5, 1996, Pages 517-523

  Miyauchi, Tsutomu ^a   Wahl, Richard L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

2 18F fluoro 2 deoxy D glucose; Lung; Positron emission tomography; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE;

ADULT; AGED; ARTICLE; BLOOD FLOW; CANCER SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; LUNG METASTASIS; LUNG SCINTISCANNING; MALE; POSITRON EMISSION TOMOGRAPHY; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; IMAGE PROCESSING; LABORATORY DIAGNOSIS; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MIDDLE AGED; SCINTISCANNING; TIME;

BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DEOXYGLUCOSE; FALSE NEGATIVE REACTIONS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029664308     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00833385     Document Type: Article

References (24)

1. Warburg O, Posener K, Negelein E. The metabolism of the carcinoma cell. In: The metabolism of tumors. New York: Richard R. Smith; 1931: 29-169.
2. Weber G. Enzymology of cancer cells (first of two parts). N Engl J Med 1977; 296: 486-492.
3. Weber G. Enzymology of cancer cells (second of two parts). N Engl J Med 1977; 296: 541-551.
4. Wahl RL, Hutchins GD, Buchsbaum DJ, Liebert M, Grossman HB, Fisher S. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 1991; 67: 1544-1550.
5. Gritters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 1993; 344: 1420-1427.
6. Toorongian SA, Mulholand GK, Jewett DM, Bachelor MA, Kilbourn MR. Routine production of 2-deoxy-2[F-18]fluoro-D-glucose by nucleophilic exchange on a quaternary 4-amino-pyridinium resin. Int J Rad Appl Instrum [B] 1990; 17: 273-279.
7. Wahl RL, Cody RL, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991; 179: 765-770.
8. 18F)-fluoro-D-glucose: pilot animal and human studies. J Urol 1991; 146: 1470-1474
9. Newman JS, Francis IR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994; 190: 111-116.
10. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189: 847-850.
11. 18F]fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 1982; 23: 1133-1137.
12. Nolop KB, Rhodes CG, Brudin LH, Beaney RP, Krausz T, Jones T, Hughes JM. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60: 2682-2689.
13. Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, Jingu K, Masuda K. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991; 32: 1655-1660.
14. Okada J, Yoshikawa K, Imazeki K, Minoshima S, Uno K, Itami J, Kuyama J, Maruno H, Arimizu N. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. J Nucl Med 1991; 32: 686-691.
15. Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993; 34: 1190-1197.
16. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
17. Millar AB, Denison DM. Vertical gradients of lung density in healthy supine men. Thorax 1989; 44: 485-490.
18. Verschakelen JA, Van Fraeyenhoven L, Laureys G, Demedts M, Baert AL. Differences in CT density between dependent and nondependent portions of the lung: influence of lung volume. Am J Roentgenol 1993; 161: 713-717.
19. Rosenblum LJ, Mauceri RA, Wellenstein DE, Thomas FD, Bassano DA, Raasch BN, Chamberlain CC, Heitzman ER. Density patterns in the normal lung as determined by computed tomography. Radiology 1980; 137: 409-416.
20. Wollmer P, Albrechtsson U, Brauer K, Eriksson L, Jonson B, Tylen U. Measurement of pulmonary density by means of X-ray computerized tomography. Relation to pulmonary mechanics in normal subjects. Chest 1986; 90: 387-391.
21. Schuster DP, Marklin GF, Mintun MA, Ter-Pogossian MM. PET measurement of regional lung density: 1. J Comput Assist Tomogr 1986; 10: 723-729.
22. Rhodes CG, Wollmer P, Fazio F, Jones T. Quantitative measurement of regional extravascular lung density using positron emission and transmission tomography. J Comput Assist Tomogr 1981; 5: 783-791.
23. Kessler RM, Ellis J Jr, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984; 8: 514-522.
24. Wahl RL, Zasadney KR, Strand BL, Minn HRI. FDG-PET in patients with untreated breast cancers and untreated lung cancers: comparison of FDG uptake and influx [abstract]. J Nucl Med 1995; 36: 83P.